Ein System für zellbasierten Screening

Patent europeic · EP1314980 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1314980
Numer da la dumonda
EP03004224
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
25-02-2000
Publitgà
28-05-2003
Concedì
09-12-2009
Stritgà
24-02-2020
Motiv
Durada maximala cuntanschida
Classas IPC
G01N 15/14 (2006.01)
G01N 33/50 (2006.01)
C12M 1/34 (2006.01)
Prioritad
US 122152 P 26.02.1999
US 123399 P 08.03.1999
US 352171 12.07.1999
Derivà da
EP00914701
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 03-03-2020

    Durada maximala cuntanschida

    Published in Swissreg on 03.03.2020

  2. 31-03-2010

    Adressa midada

    Owner
    Cellomics, Inc., 635 William Pitt Way, Pittsburgh, PA 15238, USA → Cellomics, Inc., 100 Technology Drive, Pittsburgh, PA 15219-3130, USA

    Published in Swissreg on 31.03.2010

  3. 20-01-2010

    Represchentant inscrit

    Representative
    Hans Ulrich Seifert, Seifert & Partner, Pestalozzistrasse 2 /Postfach 1416, 8201 Schaffhausen

    Published in Swissreg on 20.01.2010

  4. 09-12-2009

    Concedì

    Published in Swissreg on 09.12.2009

Partidas

Possessur

Cellomics Inc.

Cellomics, Inc.

100 Technology Drive, Pittsburgh, PA 15219-3130, US

Represchentant

Hans Ulrich Seifert Seifert & Partner

Pestalozzistrasse 2 /Postfach 1416, 8201 Schaffhausen

Inventur

Giuliano, Kenneth, A.

Pittsburgh, PA 15209, US

Kapur, Ravi

Gibsonia, PA 15044, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.